Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00862498 · ClinicalTrials.gov registry record · NA

Examining Written Disclosure as a Treatment for Post-Traumatic Stress Disorder

A NA study, sponsored by Boston University.

Completed
Registry status
NA
Development phase
48
Enrollment target

NCT00862498 is a NA study that has completed, run by Boston University. The registered enrollment target is 48 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00862498, a NA study, has completed, sponsored by Boston University.

COMPLETED
Registry status
NA
Development phase
48 participants
Enrollment target

Study Summary

This study will test the effectiveness of writing about a traumatic incident to treat post-traumatic stress disorder in people who have been in car accidents.

Interventions

  • OTHER Written Disclosure

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2008-08
Est. Completion 2011-08
Phase NA

Sponsor

Boston University

185 total trials

What the Registry Record Tells You About NCT00862498

The ClinicalTrials.gov registry entry for NCT00862498 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston University, which has 185 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which Written Disclosure is the first listed.

NCT00862498 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00862498 about?

NCT00862498 is a clinical study titled "Examining Written Disclosure as a Treatment for Post-Traumatic Stress Disorder". This study will test the effectiveness of writing about a traumatic incident to treat post-traumatic stress disorder in people who have been in car accidents.

What is the current status of trial NCT00862498?

This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2008-08. Estimated completion is 2011-08.

What interventions are being tested in trial NCT00862498?

The interventions under investigation include: Written Disclosure (OTHER).

Who is sponsoring clinical trial NCT00862498?

This trial is sponsored by Boston University, which has 185 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.